Dr. Lankenau spoke about hurdles to Pennsylvania's path to legalizing cannabis.

Assistant Director Jim Seaberg weighs in on a new study about elevated levels of lead in the blood of marijuana users.

Assistant Director Jim Seaberg weighs in on a new study about elevated levels of lead in the blood of marijuana users.

Assistant Director Jim Seaberg weighs in on a new study about elevated levels of lead in the blood of marijuana users.

Assistant Director Jim Seaberg was interviewed about a new study that found marijuana users had elevated levels of lead in their blood.

A study led by Dr. Wei Du, co-director of the Medical Cannabis Research Center, was featured in a May 16 Healthline article. The study found that diverse forms of cannabis improved the quality of life for patients living with chronic pain.

Center director Stephen Lankenau, PhD, and Ekaterina Fedorova, DrPH, senior research scientist, were interviewed along with other Pennsylvanians who are involved in the cannabis industry in various ways.

Center director Stephen Lankenau, PhD, and Ekaterina Fedorova, DrPH, senior research scientist, were interviewed along with other Pennsylvanians who are involved in the cannabis industry in various ways.

The Center was mentioned in this Montco Today article about ongoing research on medical cannabis and the effects it has on various conditions covered by Pennsylvania’s chapter 20 clinical registrant program.

The Center was mentioned in this article about the opening of the Pittsburgh area’s first medical cannabis drive-thru.

The Center was mentioned in this article about the opening of the Pittsburgh area’s first medical cannabis drive-thru.

Center director Stephen Lankenau, PhD, was quoted in this KYW Newsradio piece.

Research teams from eight Pennsylvania medical schools are preparing medical marijuana studies in collaboration with cannabis producers.

Three clinical research centers have been chosen to investigate the potential benefits and risks of using medical marijuana to treat health conditions.

The Pennsylvania Department of Health on Thursday announced that it had approved three companies to grow medical marijuana for research in partnership with medical schools at Drexel, Thomas Jefferson, and Penn State in Hershey, Pa.

Drexel University will partner with Agronomed Biologics LLC to investigate the potential benefits and risks of using medicinal cannabis to treat health conditions.

Drexel University is one of several local research universities to secure an Academic Clinical Research Center permit from the state Department of Health, which oversees Pennsylvania’s medical marijuana program.